File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Radiofrequency ablation for malignant liver tumor

TitleRadiofrequency ablation for malignant liver tumor
Authors
KeywordsAblation
Liver
Malignant
Radiofrequency
Tumor
Issue Date2005
PublisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/suronc
Citation
Surgical Oncology, 2005, v. 14 n. 1, p. 41-52 How to Cite?
AbstractRadiofrequency ablation (RFA) has been widely practiced to treat unresectable malignant liver tumors. It has the merits of localized tumor ablation and preservation of maximal normal liver parenchyma. In recent years, there has been a tremendous expansion in the application of RFA for patients with malignant liver tumors. However, the therapeutic effect of this local ablation treatment needs to be balanced against its risks and possible local failure. This review focuses on the current status of RFA for malignant liver tumors, with special attention to the indication, approaches, complications, survival benefits, combination therapies, and comparison with other treatment modalities. Although the results of most clinical studies of RFA seem favorable, the associated risks and tumor recurrence should not be underestimated. Careful patient selection, meticulous RFA techniques, and prompt treatment of residual and recurrent tumors are necessary to ensure a better outcome after RFA. Until recently, there has been no strong evidence showing that RFA can replace any other treatment modalities in the management of liver tumors. Nonetheless, more convincing evidence by randomized trials is required for the establishment of a treatment protocol of RFA for patients with malignant liver tumors. © 2005 Elsevier Ltd. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/84532
ISSN
2015 Impact Factor: 3.514
2015 SCImago Journal Rankings: 1.475
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorNg, KKen_HK
dc.contributor.authorPoon, RTen_HK
dc.date.accessioned2010-09-06T08:54:03Z-
dc.date.available2010-09-06T08:54:03Z-
dc.date.issued2005en_HK
dc.identifier.citationSurgical Oncology, 2005, v. 14 n. 1, p. 41-52en_HK
dc.identifier.issn0960-7404en_HK
dc.identifier.urihttp://hdl.handle.net/10722/84532-
dc.description.abstractRadiofrequency ablation (RFA) has been widely practiced to treat unresectable malignant liver tumors. It has the merits of localized tumor ablation and preservation of maximal normal liver parenchyma. In recent years, there has been a tremendous expansion in the application of RFA for patients with malignant liver tumors. However, the therapeutic effect of this local ablation treatment needs to be balanced against its risks and possible local failure. This review focuses on the current status of RFA for malignant liver tumors, with special attention to the indication, approaches, complications, survival benefits, combination therapies, and comparison with other treatment modalities. Although the results of most clinical studies of RFA seem favorable, the associated risks and tumor recurrence should not be underestimated. Careful patient selection, meticulous RFA techniques, and prompt treatment of residual and recurrent tumors are necessary to ensure a better outcome after RFA. Until recently, there has been no strong evidence showing that RFA can replace any other treatment modalities in the management of liver tumors. Nonetheless, more convincing evidence by randomized trials is required for the establishment of a treatment protocol of RFA for patients with malignant liver tumors. © 2005 Elsevier Ltd. All rights reserved.en_HK
dc.languageengen_HK
dc.publisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/suroncen_HK
dc.relation.ispartofSurgical Oncologyen_HK
dc.rightsSurgical Oncology. Copyright © Elsevier Ltd.en_HK
dc.subjectAblationen_HK
dc.subjectLiveren_HK
dc.subjectMalignanten_HK
dc.subjectRadiofrequencyen_HK
dc.subjectTumoren_HK
dc.titleRadiofrequency ablation for malignant liver tumoren_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0960-7404&volume=14&issue=1&spage=41&epage=52&date=2005&atitle=Radiofrequency+ablation+for+malignant+liver+tumoren_HK
dc.identifier.emailPoon, RT: poontp@hkucc.hku.hken_HK
dc.identifier.authorityPoon, RT=rp00446en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.suronc.2005.01.001en_HK
dc.identifier.pmid15777889en_HK
dc.identifier.scopuseid_2-s2.0-15044360254en_HK
dc.identifier.hkuros118498en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-15044360254&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume14en_HK
dc.identifier.issue1en_HK
dc.identifier.spage41en_HK
dc.identifier.epage52en_HK
dc.identifier.isiWOS:000228135200005-
dc.publisher.placeUnited Kingdomen_HK
dc.identifier.scopusauthoridNg, KK=35248894000en_HK
dc.identifier.scopusauthoridPoon, RT=7103097223en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats